people in a business meeting

Admission: Elixirr International plc

Mitesh Patelia
01/07/2025
people in a business meeting
£325 million London Stock Exchange Main Market admission.

Elixirr is a global, award-winning management consultancy business, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally recognised client base.

Elixirr, which was founded in 2009, offers a wide range of expertise and capabilities, including defining strategy and driving business improvement with the aim of solving the challenges experienced by its clients.

Crowe advised Elixirr on its successful admission to trading on AIM in 2020. Since admission to AIM, the business has evolved through a combination of organic growth and acquisitions.

Crowe's role and team

Crowe acted as reporting accountant on Elixirr’s successful admission to the Main Market. The team was led by Mitesh Patelia, George Lawford, James Leyton and Toby Gobourn.

Client quote

"We believe that the transition from AIM to the Main Market will unlock greater access to capital and liquidity, enhance the firm’s brand recognition, and position Elixirr to attract world-class talent and global investment. We appreciated the support of Crowe’s Capital Markets team during the transaction and look forward to working with them in the future."

Graham Busby, Founder & Deputy CEO, Elixirr

Our recent deals

Insert Clear Filter Text
loading gif
people working on laptop at night
Acquisition: Wilmington plc
Crowe provided buy-side advisory support, as well as financial and tax due diligence
people in a business meeting
Admission: Elixirr International plc
£325 million London Stock Exchange Main Market admission.
hand holding microchip above a circuit board
Acquisition: RoBAT Limited
Mycronic AB (publ) completes the acquisition of RoBAT Limited and its subsidiaries.
Pipette
Sale: Lexica
Crowe advises Guy’s and St Thomas’ Trust on the sale of Lexica to WSP.
man looking at tablet
Admission: MHA plc
£98 million placing, retail offer and admission to trading on AIM.
doctor speaking to a patient
Admission: One Health Group plc
Admission to trading on the AIM market of the London Stock Exchange.
people working on laptop at night
Acquisition: Wilmington plc
Crowe provided buy-side advisory support, as well as financial and tax due diligence
people in a business meeting
Admission: Elixirr International plc
£325 million London Stock Exchange Main Market admission.
hand holding microchip above a circuit board
Acquisition: RoBAT Limited
Mycronic AB (publ) completes the acquisition of RoBAT Limited and its subsidiaries.
Pipette
Sale: Lexica
Crowe advises Guy’s and St Thomas’ Trust on the sale of Lexica to WSP.
man looking at tablet
Admission: MHA plc
£98 million placing, retail offer and admission to trading on AIM.
doctor speaking to a patient
Admission: One Health Group plc
Admission to trading on the AIM market of the London Stock Exchange.